Q1 Result Update: Mold-Tek Packaging Net Profit Surges 14% Annually, Net Sales Up 26%

Mold-Tek Packaging Q1 Result

The company's profit after tax (PAT) surged by 14.2% to Rs 35.57 crore in the first quarter of financial year 2026-27 against Rs 22.4 crore in the same period year ago. Mold-Tek's net sales increased by 26.32% on a year-on-year basis. The jump was driven by healthy demand across all business segments.

EBITDA Growth

The company's EBITDA surged by 17.31% which was supported by enhanced operational efficiency and effective cost management. Sales volume also surged by 5.82% on an annual basis during the quarter under review.

Segment Wise Volume Growth

The company's pharma packs posted a strong 38.75% sales volume growth, whereas, its food & FMCG packet grew by 26.2% on a yearly basis. Paints pack segment grew by 10.82%, however there was a decline in demand in the lubricant segment.

"There is a humongous opportunity in Pharma Packaging including diagnostics and we have plans to enter into these high margin areas including dosage pens. We also examining ways to enter Electronics and Semi-conductor packaging soon to use our deep knowledge in Mold making and Robotics," stated J Rana Pratap, Sr. Vice President-Marketing and in-charge of Pharma Business division.

Mold-Tek Packaging Share Price Trend

The stock closed lower on Tuesday.The stock hit its 52-week high mark of Rs 890 per share on July 30, 2025. The stock dipped to its 52-week low mark of Rs 453.80 per share on March 30, 2026. The stock has a return on equity (ROE) of 12.19%. Its share price value has declined around 4.34% in month and around 15.43% in three months.

Disclaimer: The views and recommendations expressed are solely those of the individual analysts or entities and do not reflect the views of Goodreturns.in or Greynium Information Technologies Private Limited (together referred as "we"). We do not guarantee, endorse or take responsibility for the accuracy, completeness or reliability of any content, nor do we provide any investment advice or solicit the purchase or sale of securities. All information is provided for informational and educational purposes only and should be independently verified from licensed financial advisors before making any investment decisions.